GSK shares surge as US judge dismisses Zantac cancer claims
by Joe Middleton and agencies from on (#66KKT)
About 50,000 federal lawsuits claimed that the bestselling heartburn drug had led to cancer
Shares in drug firms GlaxoSmithKline and Sanofi surged after a US judge dismissed thousands of lawsuits claiming that the heartburn drug Zantac caused cancer.
GSK's shares jumped as much as 14% in early trading, while Sanofi's stock jumped nearly 6% in mid-morning trading.
Continue reading...